FDA Faces Scrutiny Over Authorization of Fruit-Flavored E-Cigarettes

The U.S. Food and Drug Administration (FDA) is facing mounting criticism following its recent decision to authorize fruit-flavored e-cigarettes from manufacturer Glas Inc. While the agency has historically maintained that flavored vapes must demonstrate a clear public health benefit—specifically by proving they are more effective at helping adults quit smoking than tobacco-flavored alternatives—a newly released internal memo reveals that the Glas products failed to meet this statistical threshold.

Despite the lack of evidence showing that mango and blueberry flavors outperform tobacco-flavored options, the FDA justified the approval by citing the manufacturer’s age-verification technology. The agency argued that because the product requires a smartphone app to unlock, the risk of underage use is mitigated, thereby lowering the evidentiary burden typically required for non-tobacco flavors. This stance appears to deviate from the FDA’s own established guidelines, which previously signaled that fruit and dessert flavors would face rigorous scrutiny due to their potential appeal to minors.

This decision has drawn sharp rebukes from lawmakers and public health advocates, who are questioning the transparency and consistency of the agency’s regulatory process. The controversy is further fueled by the unusual brevity of the FDA’s justification memo, which spans only six pages compared to the exhaustive, multi-page reports typically associated with such authorizations. Critics, including a group of Democratic senators, have labeled the move as reckless, particularly given the lack of detailed data regarding the study’s scope and participant demographics.

The authorization marks a significant shift in regulatory tone, occurring during a period of leadership transition within the agency. As the FDA faces pressure to explain its rationale, the incident highlights the ongoing tension between promoting harm-reduction tools for adult smokers and preventing the widespread adoption of nicotine products among youth. For the industry, this development underscores the unpredictable nature of the FDA’s current approval landscape and the potential for future legal or legislative challenges regarding flavored vape products.